- Q1 2024 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024€28.8 (+2.13%)Earnings
- Q4 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2024€27 (+1.50%)Earnings
- Q3 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023€22.2Earnings
- Supernus Pharmaceuticals Inc R&D Day TranscriptOct 18, 2023
- Q2 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023€29 (-0.68%)Earnings
- Supernus Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023€33.2 (+0.61%)Earnings
- Q4 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2023Earnings
- Q3 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022€34.4 (+1.18%)Earnings
- Q2 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022€31.2Earnings
- Q1 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2022€25.8 (-2.27%)Earnings
- Preliminary Q4 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2022€27 (-4.93%)Earnings
- Q3 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021€25.6 (-0.78%)Earnings
- Supernus Pharmaceuticals Inc Acquisition of Adamas Pharmaceuticals Inc - M&A Call TranscriptOct 11, 2021
- Supernus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2021€22.6 (+0.89%)Earnings
- Q1 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021€25 (-1.57%)Earnings
- Supernus Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021€26 (+9.24%)Earnings
- Supernus Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2020€17.5 (+12.18%)Earnings
- Supernus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Q2 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 19, 2020€21.4 (+3.88%)Earnings
- Q1 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020€20.2Earnings
- Supernus Pharmaceuticals Inc to Acquire the CNS portfolio of Us WorldMeds LLC - Conference Call TranscriptApr 29, 2020
- Q4 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 26, 2020€17.8 (-18.35%)Earnings
- Supernus Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 06, 2019€19.8 (-25.56%)Earnings
- Supernus Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2019€26.27 (-7.63%)Earnings
- Q1 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2019€28.06 (-17.06%)Earnings
- Supernus Pharmaceuticals Inc Investor Day TranscriptApr 16, 2019
- Supernus Pharmaceuticals Inc to Discuss the SPN-812 Phase III Topline Results - Conference Call TranscriptMar 28, 2019
- Supernus Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 13, 2019
- Q4 2018 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2019€33.9 (+4.12%)Earnings
Q2 2020 Supernus Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to Supernus Pharmaceuticals Second Quarter 2020 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to Peter Vozzo of Westwicke, Investor Relations representative for Supernus Pharmaceuticals. You may begin.
Thank you, Sarah. Good morning, everyone, and thank you for joining us today for Supernus Pharmaceuticals' Second Quarter 2020 Financial Results Conference Call. Yesterday, after the close of the market, the company issued a press release announcing these results.
On the call with me today are Supernus' Chief Executive Officer, Jack Khattar; and Chief Financial Officer, Greg Patrick. Today's call is being made available via the Investor Relations section of the company's website at ir.supernus.com.
During the course of this call, management may make certain forward-looking statements regarding future events and the company's future performance. These forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)